Prospectus
Supplement
(To Prospectus dated November
26, 2021)
Weibo
Corporation
11,000,000 Class A
Ordinary Shares
This prospectus supplement
relates to an offering of an aggregate of 11,000,000 Class A
ordinary shares, par value US$0.00025 per share, of Weibo
Corporation. We are offering 5,500,000 Class A ordinary
shares, par value US$0.00025 per share, and the selling shareholder
identified in this prospectus supplement is offering 5,500,000
Class A ordinary shares (to be converted from the Class B
ordinary shares prior to the listing of our Class A ordinary shares
on The Stock Exchange of Hong Kong Limited, or the Hong Kong Stock
Exchange) as part of a global offering, or the Global Offering,
consisting of an international offering of 9,900,000 Class A
ordinary shares offered hereby, and a Hong Kong public offering of
1,100,000 Class A ordinary shares. The public offering price
for the international offering and the Hong Kong public offering is
HK$272.80 per Class A ordinary share, or approximately
US$35.01 per Class A ordinary share based on an exchange rate
of HK$7.7915 to US$1.00. We will not receive any proceeds from the
sale of the Class A ordinary shares to be offered by the selling
shareholder identified in this prospectus supplement.
Our American depositary
shares, or ADSs, are listed on the Nasdaq Global Select Market
under the symbol “WB.” On December 1, 2021, the last reported
trading price of our ADSs on the Nasdaq Global Select Market was
US$36.00 per ADS, or HK$280.49 per Class A ordinary share,
based upon an exchange rate of HK$7.7915 to US$1.00. Each ADS
represents one Class A ordinary share.
The international offering
contemplated herein consists of a U.S. offering and a non-U.S.
offering made outside the United States in compliance with
applicable law. We are paying a registration fee for Class A
ordinary shares sold in the United States, as well as for
Class A ordinary shares initially offered and sold outside the
United States in the Global Offering that may be resold from time
to time into the United States.
Approval-in-principal has been
granted by the Hong Kong Stock Exchange pursuant to Chapter 19C of
the Hong Kong Stock Exchange Listing Rules, for the listing of, and
permission to deal in, our Class A ordinary shares under the stock
code “9898.”
See “Risk Factors” beginning
on page S-24 of this
prospectus supplement and in any documents incorporated by
reference into this prospectus supplement for a discussion of
certain risks that should be considered in connection with an
investment in our Class A ordinary shares.
Weibo Corporation is not an
operating company but a Cayman Islands holding company with
operations primarily conducted by our subsidiaries in China and
through contractual arrangements with our variable interest
entities based in China. PRC laws and regulations restrict and
impose conditions on foreign direct investment in companies
involved in the provision of internet information services and
other related services. Therefore, we operate such business in
China through our variable interest entities, which we refer to as
our VIEs in this prospectus supplement, and rely on contractual
arrangements among our PRC subsidiaries, our VIEs and their nominee
shareholders to control the business operations of our VIEs.
Investors in our ADSs thus are not purchasing equity interest in
our operating entities in China but instead are purchasing equity
interest in a Cayman Islands holding company. As used in this
prospectus supplement, “Weibo,” “we,” “us,” “our company” or “our”
refers to Weibo Corporation, its subsidiaries, and, in the context
of describing our operations and consolidated financial
information, our VIEs and their subsidiaries in China.
We face various legal and
operational risks and uncertainties associated with being based in
or having our operations primarily in China and the complex and
evolving PRC laws and regulations. For example, we face risks
associated with regulatory approvals on offerings conducted
overseas by and foreign investment in China-based issuers, the use
of our VIEs, anti-monopoly regulatory actions, and oversight on
cybersecurity and data privacy, as well as the lack of PCAOB
inspection on our auditors, which may impact our ability to conduct
certain businesses, accept foreign investments, or list on foreign
exchange outside of China. These risks could result in a material
adverse change in our operations and the value of our ADSs,
significantly limit or completely hinder our ability to offer or
continue to offer securities to investors, or cause the value of
such securities to significantly decline.
Our corporate structure is
subject to risks associated with our contractual arrangements with
our VIEs. Investors may never directly hold equity interests in our
VIEs. If the PRC government finds that the agreements that
establish the structure for operating our business do not comply
with PRC laws and regulations, or if these regulations or their
interpretations change in the future, we could be subject to severe
penalties or be forced to relinquish our interests in those
operations. Our holding company, our PRC subsidiaries, our VIEs,
and investors of our company face uncertainty about potential
future actions by the PRC government that could affect the
enforceability of the contractual arrangements with our VIEs and,
consequently, significantly affect the financial performance of our
VIEs and our company as a whole.
Neither the United States
Securities and Exchange Commission (the “SEC”) nor any state
securities commission has approved or disapproved of these
securities or determined that this prospectus supplement or the
accompanying prospectus is accurate or complete. Any representation
to the contrary is a criminal offense.
PRICE HK$272.80 PER CLASS A
ORDINARY SHARE
|
|
|
Per Class A
Ordinary Share
|
|
|
Total
|
|
Public offering price
|
|
|
|
HK$ |
272.80(1) |
|
|
|
HK$3,000,800,000.00
|
|
Underwriting discounts and
commissions(2)
|
|
|
|
HK$ |
5.4560 |
|
|
|
HK$ 60,016,000.00
|
|
Proceeds to us (before
expenses)(3)
|
|
|
|
HK$ |
267.3440 |
|
|
|
HK$1,470,392,000.00
|
|
Proceeds to the Selling Shareholder
(before expenses)
|
|
|
|
HK$ |
267.3440 |
|
|
|
HK$1,470,392,000.00
|
|
(1)
Equivalent to US$35.01 per
ADS, based upon each ADS representing one Class A ordinary
share and an exchange rate of HK$7.7915 to US$1.00 as of November
19, 2021, as set forth in the H.10 statistical release of The Board
of Governors of the Federal Reserve System.
(2)
See “Underwriting” beginning
on page S-63 of this
prospectus supplement for additional information regarding total
underwriting compensation.
(3)
Includes net proceeds of
HK$294,078,400.00 from the sale of 1,100,000 Class A ordinary
shares in the Hong Kong public offering.
The selling shareholder
identified in this prospectus supplement has granted the
international underwriters the option, exercisable by Goldman Sachs
(Asia) L.L.C., Credit Suisse (Hong Kong) Limited, CLSA Limited and
China International Capital Corporation Hong Kong Securities
Limited, or the Joint Representatives, on behalf of the
international underwriters, to purchase up to an additional
1,650,000 Class A ordinary shares at the public offering price
until 30 days after the last day for the lodging of
applications under the Hong Kong public offering. Goldman Sachs
International, an affiliate of Goldman Sachs (Asia) L.L.C., has
entered into a borrowing arrangement with WB HZGS Estate (Hong
Kong) Limited to facilitate the settlement of over-allocations.
Goldman Sachs International, an affiliate of Goldman Sachs (Asia)
L.L.C., is obligated to return Class A ordinary shares to WB
HZGS Estate (Hong Kong) Limited by causing Goldman Sachs (Asia)
L.L.C. to exercise the option to purchase additional Class A
ordinary shares from the Selling Shareholder or by making purchases
in the open market. No fees or other remuneration will be paid by
the underwriters to us or WB HZGS Estate (Hong Kong) Limited for
the loan of these Class A ordinary shares.
The underwriters expect to
deliver the Class A ordinary shares against payment therefor
through the facilities of the Central Clearing and Settlement
System on or around December 8, 2021.
Joint Sponsors, Joint Global
Coordinators, Joint Bookrunners and Joint Lead
Managers
Goldman Sachs
Credit
Suisse CLSA
CICC
Joint Global Coordinators,
Joint Bookrunners and Joint Lead Managers
|
Nomura
|
|
|
Deutsche Bank
|
|
Joint Bookrunners and Joint
Lead Managers
|
Haitong International
|
|
|
Huatai
|
|
|
Valuable Capital
|
|
|
ABCI
|
|
|
CMBC
|
|
|
CMBI
|
|
Prospectus supplement dated
December 2, 2021.